AT383126B - Verfahren zur herstellung von neuen carbapenem-antibiotika - Google Patents

Verfahren zur herstellung von neuen carbapenem-antibiotika

Info

Publication number
AT383126B
AT383126B AT0125583A AT125583A AT383126B AT 383126 B AT383126 B AT 383126B AT 0125583 A AT0125583 A AT 0125583A AT 125583 A AT125583 A AT 125583A AT 383126 B AT383126 B AT 383126B
Authority
AT
Austria
Prior art keywords
producing new
carbapenem antibiotics
new carbapenem
antibiotics
producing
Prior art date
Application number
AT0125583A
Other languages
German (de)
English (en)
Other versions
ATA125583A (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to AT45286A priority Critical patent/AT387388B/de
Publication of ATA125583A publication Critical patent/ATA125583A/de
Application granted granted Critical
Publication of AT383126B publication Critical patent/AT383126B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0125583A 1982-04-08 1983-04-08 Verfahren zur herstellung von neuen carbapenem-antibiotika AT383126B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT45286A AT387388B (de) 1982-04-08 1986-02-20 Verfahren zur herstellung von neuen carbapenem-antibiotika

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36662782A 1982-04-08 1982-04-08

Publications (2)

Publication Number Publication Date
ATA125583A ATA125583A (de) 1986-10-15
AT383126B true AT383126B (de) 1987-05-25

Family

ID=23443823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0125583A AT383126B (de) 1982-04-08 1983-04-08 Verfahren zur herstellung von neuen carbapenem-antibiotika

Country Status (25)

Country Link
JP (1) JPS58188887A (da)
KR (1) KR880001055B1 (da)
AT (1) AT383126B (da)
AU (1) AU567092B2 (da)
BE (1) BE896407A (da)
CA (1) CA1198440A (da)
CH (1) CH661927A5 (da)
DE (1) DE3312517A1 (da)
DK (1) DK155983A (da)
ES (1) ES8405399A1 (da)
FI (1) FI74009C (da)
FR (1) FR2524888B1 (da)
GB (1) GB2118183B (da)
GR (1) GR78822B (da)
HU (1) HU190716B (da)
IE (1) IE55225B1 (da)
IL (1) IL68295A0 (da)
IT (1) IT1168854B (da)
LU (1) LU84739A1 (da)
MY (1) MY8700945A (da)
NL (1) NL8301193A (da)
OA (1) OA07395A (da)
PT (1) PT76518B (da)
SE (1) SE460197B (da)
ZA (1) ZA832411B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
AT396473B (de) * 1984-10-02 1993-09-27 Bristol Myers Squibb Co Verfahren zur herstellung von neuen carbapenemderivaten
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
DK165280A (da) * 1979-04-19 1980-10-20 Merck & Co Inc Fremgangsmaade til fremstilling af 2- og 6-substituerede 1-carbadethiapen-2-em-3-carboxylsyrer og mellemprodukter til brug ved udoevelse af fremgangsmaaden
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
HU185493B (en) * 1981-12-30 1985-02-28 Richter Gedeon Vegyeszet Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics

Also Published As

Publication number Publication date
GB2118183A (en) 1983-10-26
FI74009C (fi) 1987-12-10
MY8700945A (en) 1987-12-31
DK155983A (da) 1983-10-09
AU1319883A (en) 1983-10-13
SE8301928L (sv) 1983-12-02
HU190716B (en) 1986-10-28
IE55225B1 (en) 1990-07-04
FI831135L (fi) 1983-10-09
ATA125583A (de) 1986-10-15
ZA832411B (en) 1983-12-28
FI831135A0 (fi) 1983-04-05
PT76518B (en) 1986-02-06
DE3312517C2 (da) 1991-10-31
IT1168854B (it) 1987-05-20
PT76518A (en) 1983-05-01
KR840004429A (ko) 1984-10-15
ES521224A0 (es) 1984-06-01
FI74009B (fi) 1987-08-31
NL8301193A (nl) 1983-11-01
FR2524888A1 (fr) 1983-10-14
ES8405399A1 (es) 1984-06-01
GB2118183B (en) 1985-11-27
IL68295A0 (en) 1983-07-31
IE830800L (en) 1983-10-08
DE3312517A1 (de) 1983-10-20
DK155983D0 (da) 1983-04-07
JPS58188887A (ja) 1983-11-04
LU84739A1 (fr) 1983-12-05
SE8301928D0 (sv) 1983-04-07
FR2524888B1 (fr) 1985-12-13
JPH0524156B2 (da) 1993-04-06
IT8348061A0 (it) 1983-04-07
KR880001055B1 (ko) 1988-06-18
SE460197B (sv) 1989-09-18
CH661927A5 (de) 1987-08-31
AU567092B2 (en) 1987-11-12
GR78822B (da) 1984-10-02
OA07395A (fr) 1984-06-30
GB8309505D0 (en) 1983-05-11
BE896407A (fr) 1983-10-07
CA1198440A (en) 1985-12-24

Similar Documents

Publication Publication Date Title
AT368161B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT382367B (de) Verfahren zur herstellung von neuen azetidinverbindungen
AT381507B (de) Verfahren zur herstellung von neuen antibiotischen verbindungen
ATA206483A (de) Verfahren zur herstellung von neuen mitosanderivaten
ATA125383A (de) Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
AT382638B (de) Verfahren zur herstellung von neuen trehaloselipiden
ATA1285A (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT384612B (de) Verfahren zur herstellung von neuen cephalosporinderivaten
AT382620B (de) Verfahren zur herstellung von neuen carbapenem-derivaten
AT382621B (de) Verfahren zur herstellung von neuen carbapenem-derivaten
AT385035B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT386828B (de) Verfahren zur herstellung von neuen acylaminomitosanen
AT367766B (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
AT383126B (de) Verfahren zur herstellung von neuen carbapenem-antibiotika
AT387385B (de) Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen
AT385509B (de) Verfahren zur herstellung von neuen mitosanverbindungen
AT378776B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT377980B (de) Verfahren zur herstellung von neuen diastereomeren
AT387387B (de) Verfahren zur herstellung von carbapenem-antibiotika
ATA45286A (de) Verfahren zur herstellung von carbapenem-antibiotika
ATA373685A (de) Verfahren zur herstellung von neuen carbapenem-derivaten
ATA1790A (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
ATA80488A (de) Verfahren zur herstellung von neuen cephalosporin-antibiotika
ATA368980A (de) Verfahren zur herstellung von neuen aminoglykosid-antibiotika
ATA256085A (de) Verfahren zur herstellung von neuen penamverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification
EEFA Change of the company name